Nashville health care's global reach

Health care is powerful and very visible force in Middle Tennessee, where it accounts for one out of every eight jobs. But entities based in and around Nashville also have an international reach that touches millions of people on just about every continent. Here, from our new Healthier magazine out new, are just a few data points.

Jun 10, 2014 5:32 AM

Earnings wrap: Emdeon, Cumberland

Transaction processor sees sales grow but operating income dip; drug marketers launched two new drugs, joint R&D venture during quarter
May 14, 2014 7:00 AM

Cumberland, Chinese company invest $2M in incubator

West End drug marketer looks to speed up development work
May 7, 2014 7:01 AM

Cumberland director to retire in April

15-year member chairs nominating committee
Mar 14, 2014 10:02 AM

Earnings wrap: First Acceptance, Cumberland

Insurer continues rebound, drug marketer revenues off 40%
Mar 5, 2014 6:43 AM

Cumberland buys blood plasma drug from Japanese company

Local venture looks to build hyponatremia treatment business through hospital network
Mar 3, 2014 10:32 AM

Earnings wrap: Cumberland, First Acceptance

Drug marketer Cumberland Pharmaceuticals lost $832,000 in its third quarter, reversing a year-ago profit of $1.9 million. Revenues were $6.5 million versus $12.5 million but operating expenses fell just 16 percent to $8.0 million. Through the first nine months of this year, the West End-based company generated just $940,000 in cash flow from operations versus more than $45million in 2012.

 
Automotive insurer First Acceptance posted a third-quarter profit of $2.1 million. That down from $3.4 million a year earlier but that quarter included more than $3 million in investment gains. The Green Hills company saw its combined ratio — which measures premiums relative to losses and operating expenses — fall to 96.3 percent from 99.9 percent the year before. The company's number of policies in force has climbed almost 7 percent this year to more than 157,000.

Nov 7, 2013 11:46 AM

Cumberland inks drug marketing deal

Partnership with Texas company bringing to market ulcer treatment
Oct 28, 2013 9:08 AM

Legal setback for Cumberland Pharma in FDA case

Drug developer sued agency last year over inconsistency in rulings
Oct 9, 2013 7:01 AM

Investors thump Cumberland after Q2 report

Shares of Cumberland Pharmaceuticals took a beating Wednesday after the company reported a second-quarter loss. At about 2 p.m., they were off more than 13 percent to $4.84, which would be their lowest close since late May. Shares ended trading for the day down 11.83 percent. Optimistic investors looking for a silver light might find one in the stock's volume, which was not even twice the average daily volume of recent weeks' sessions.

Aug 7, 2013 2:09 PM